Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2018 - Volume 22, Number 1
View All Articles in Issue

Abstract:  A formulation for preparing Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, penicillamine-D, chelating agent, heavy metals, rheumatoid arthritis, cystinuria, primary biliary cirrhosis, scleroderma, Wilson disease, copper poisoning, lead poisoning

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, ALLERGY/IMMUNOLOGY/INFLAMMATION

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4429

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products